PAX8、WT—1、HER2在不同转移方式的晚期卵巢上皮性癌中的差异表达(4)
[11] Goldstein N S，Uzieblo A.WT-l immunoreactivity in uterine papillary serous carcinomas is different from ovarian serous carcinomas[J].Am J Clin pathol，2002，117(4)：541.
[12] Al-Hussaini M，Stockman A，Foster H，et al.WT-1 assists in distinguishing ovarian from uterine serous carcinoma and in distinguishing between serous and endometrioid ovarian carcinoma[J].Histopathology，2004，4(2)：109.
[13] Huang L W，Garrett A P，Bell D A，et al.Diferential expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 protein and mRNA in epithelial ovarian tumours[J].Gynecol Oncol，2000，77(3)：369.
[14] Sebastian S，Settleman J，Reshkin S J，et al.The complexity of targeting EGFR signaling in cancer：from expression to turnover[J].Biochim Biophys Acta，2006，1766(1)：120.
[15] Suo Z，Karbovo E，Trope C G，et al.Papillary serous carcinoma of the ovary：an ultrastructural and immunohistochemieal study[J].Ultrastruct Pathol，2004，28(3)：141.
[16] Camilleri-Broet S，Hardy-Bessard A C，Le-Tourneau A，et al.HER-2 overerexpression is an independent marker of poor prognosis of advanced primary ovarian carcinoma，a multicenter study of the G1NECO group[J].Ann Oncol，2004，15(1)：104.
[17] Gessler M，Poustka A，Cavenee W，et al.Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping[J].Nature，1990，343(6260)：774.
(收稿日期：2016-07-17) (本文编辑：李颖), http://www.100md.com(王丽丽 郭红燕 张雪辉 张馨田)
[12] Al-Hussaini M，Stockman A，Foster H，et al.WT-1 assists in distinguishing ovarian from uterine serous carcinoma and in distinguishing between serous and endometrioid ovarian carcinoma[J].Histopathology，2004，4(2)：109.
[13] Huang L W，Garrett A P，Bell D A，et al.Diferential expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 protein and mRNA in epithelial ovarian tumours[J].Gynecol Oncol，2000，77(3)：369.
[14] Sebastian S，Settleman J，Reshkin S J，et al.The complexity of targeting EGFR signaling in cancer：from expression to turnover[J].Biochim Biophys Acta，2006，1766(1)：120.
[15] Suo Z，Karbovo E，Trope C G，et al.Papillary serous carcinoma of the ovary：an ultrastructural and immunohistochemieal study[J].Ultrastruct Pathol，2004，28(3)：141.
[16] Camilleri-Broet S，Hardy-Bessard A C，Le-Tourneau A，et al.HER-2 overerexpression is an independent marker of poor prognosis of advanced primary ovarian carcinoma，a multicenter study of the G1NECO group[J].Ann Oncol，2004，15(1)：104.
[17] Gessler M，Poustka A，Cavenee W，et al.Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping[J].Nature，1990，343(6260)：774.
(收稿日期：2016-07-17) (本文编辑：李颖), http://www.100md.com(王丽丽 郭红燕 张雪辉 张馨田)